Long-term graft survival of living-related kidneys after donor-specific transfusion.
Otsuka
M
M
University of Tsukuba, Ibaraki, Japan.
Yuzawa
K
K
Takada
Y
Y
Taniguchi
H
H
Fukunaga
K
K
Seino
K
K
Todoroki
T
T
Fukao
K
K
D001379:Azathioprine / Q000627:therapeutic use; D001782:Blood Donors; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005190:Family; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D019520:Living Donors; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine